Full Press Release Details
evkeeza evinacumab dgnb angptl3 antibody approved in the u s for children as young as 1 year old with ultra rare form of high cholesterol.
REGN
evkeeza evinacumab dgnb angptl3 antibody approved in the u s for children as young as 1 year old with ultra rare form of high cholesterol
Key Takeaway: evkeeza evinacumab dgnb angptl3 antibody approved in the u s for children as young as 1 year old with ultra rare form of high cholesterol